Ikarian Capital, LLC Altamira Therapeutics Ltd. Transaction History

Ikarian Capital, LLC

  • $573 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$0.48 - $1.66 $117,604 - $406,716
-245,010 Reduced 76.56%
75,000 $36,000
Q1 2022

May 13, 2022
BUY
$0.69 - $1.92 $10,501 - $29,220
15,219 Added 4.99%
320,010 $351,000
Q4 2021

Feb 14, 2022
SELL
$1.28 - $2.4 $120,776 - $226,456
-94,357 Reduced 23.64%
304,791 $553,000
Q3 2021

Nov 15, 2021
BUY
$2.01 - $3.58 $802,287 - $1.43 Million
399,148 New
399,148 $803,000

About Altamira Therapeutics Ltd.

CYTO Quotes by TradingView
  • Ticker CYTO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,009,710
  • Market Cap $172K
  • Description
  • Altamira Therapeutics Ltd. engages in developing therapeutics that address various unmet medical needs. Its commercial products include Bentrio, a drug-free nasal spray for personal protection against airborne viruses and allergens. The company is also involved in the development of RNA therapeutics for extrahepatic therapeutic targets, includin...
More about CYTO
Track This Portfolio

Track Ikarian Capital, LLC Portfolio

Follow Ikarian Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ikarian Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email